PATENT CLAIM ANALYSIS

Application Number: 16271171
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "210210"]

Abstract:
Compounds of formula (I): wherein A 1 , A 2 , R a , R b , R c , R d , R 3 , R 4 , R 5  and T are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Claim (Index 8):
The process according to  claim 1 , wherein R a  and R d  each represent a hydrogen atom and (R b ,R c ), together with the carbon atoms carrying them, form a 1,3-dioxolane group or a 1,4-dioxane group; or R a , R c  and R d  each represent a hydrogen atom and R b  represents a hydrogen atom, a halogen atom, or a methoxy group.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.6087
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15419228', '14797532', '14336311', '14905877', '15428493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8272287255250922
- 35 USC 102 Novelty (BERT): 0.6211972134450096
- Combined Prediction Score: 0.8066255743170839
- Mean Citation Score: 529.189402
- Max Citation Score: 549.1958
- Similarity Product: 525.8057351555824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test